Skip to main content

Table 1 Patient characteristics on admission, Yemen (2010–2013)

From: High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen

Drug

Site

Year

n

Males

(%)

Age <5 years

Temp °C

Febrile patientsa ≥37.5

n (%)

Parasitaemia (/μL)

n (%)

95 % CI

Mean (SD)

Geometric mean (95 % CI)

AS + SP

Al-Udayn

2010

85

44

(51.8)

48 (56.5)

(45.3–67.2)

37.9 (0.2)

70 (82.4)

3429 (2643–4449)

AS + SP

Sharas

2010

93

52

(55.9)

31 (33.3)

(23.9–43.9)

37.7 (0.1)

56 (60.2)

9088 (6947–11,890)

AS + SP

Tur Bani Qa’is

2010

95

58

(61.1)

38 (40)

(30.1–50.6)

37.9 (0.3)

75 (78.9)

14543 (10,325–18,628)

AS + SP

Al Qaflaha

2011

90

42

(46.7)

33 (36.7)

(26.7–47.5)

37.6 (0.7)

55 (61.1)

3238 (2506–4184)

AS + SP

Bajil

2013

102

51

(50.0)

10 (9.8)

(4.8–17.3)

38.0 (0.4)

45 (44.1)

7011 (5461–8999)

AL

Bajil

2009–10

80

43

(53.8)

7 (8.8)

(3.6–17.2

37.6 (0.4)

74 (92.5)

12,606 (8707–18,248)

AL

Jabal Al Sharq

2010

95

57

(60.0)

14 (14.7)

(8.3–23.5)

37.6 (0.3)

57 (60)

1729 (1399–2137)

AL

Tur Bani Qa’is

2013

93

67

(72.0)

8 (8.6)

(3.8–16.2)

38.0 (0.1)

81 (87.1)

11,872 (8698–16,203)

  1. aFebrile patients: axillary temp ≥ 37.5 °C